IL64314A - 2-oxoazetidine derivatives,their production and antimicrobial and beta-lactamase inhibitory compositions containing them - Google Patents

2-oxoazetidine derivatives,their production and antimicrobial and beta-lactamase inhibitory compositions containing them

Info

Publication number
IL64314A
IL64314A IL64314A IL6431481A IL64314A IL 64314 A IL64314 A IL 64314A IL 64314 A IL64314 A IL 64314A IL 6431481 A IL6431481 A IL 6431481A IL 64314 A IL64314 A IL 64314A
Authority
IL
Israel
Prior art keywords
antimicrobial
beta
production
amino group
compositions containing
Prior art date
Application number
IL64314A
Other languages
English (en)
Other versions
IL64314A0 (en
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1980/000296 external-priority patent/WO1982001872A1/fr
Priority claimed from PCT/JP1981/000102 external-priority patent/WO1982003858A1/fr
Priority claimed from PCT/JP1981/000192 external-priority patent/WO1983000690A1/fr
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of IL64314A0 publication Critical patent/IL64314A0/xx
Publication of IL64314A publication Critical patent/IL64314A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL64314A 1980-12-05 1981-11-19 2-oxoazetidine derivatives,their production and antimicrobial and beta-lactamase inhibitory compositions containing them IL64314A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1980/000296 WO1982001872A1 (fr) 1980-12-05 1980-12-05 Derives azetidine et leur procede de preparation
PCT/JP1981/000102 WO1982003858A1 (fr) 1981-04-30 1981-04-30 Derives d'azetidine et procede de preparation
PCT/JP1981/000192 WO1983000690A1 (fr) 1981-08-25 1981-08-25 Derives d'azetidine et leur procede de preparation

Publications (2)

Publication Number Publication Date
IL64314A0 IL64314A0 (en) 1982-02-28
IL64314A true IL64314A (en) 1988-06-30

Family

ID=27303167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL64314A IL64314A (en) 1980-12-05 1981-11-19 2-oxoazetidine derivatives,their production and antimicrobial and beta-lactamase inhibitory compositions containing them

Country Status (26)

Country Link
US (1) US4822790A (fr)
EP (1) EP0053815B1 (fr)
JP (1) JPS57131759A (fr)
KR (1) KR880001564B1 (fr)
AT (3) ATE13178T1 (fr)
AU (1) AU551463B2 (fr)
CH (1) CH656122A5 (fr)
DE (2) DE3170437D1 (fr)
DK (1) DK534381A (fr)
ES (2) ES507716A0 (fr)
FI (1) FI79528C (fr)
FR (1) FR2495612A1 (fr)
GB (1) GB2091723B (fr)
HU (1) HU189545B (fr)
IE (1) IE53451B1 (fr)
IL (1) IL64314A (fr)
IT (1) IT1146726B (fr)
LU (1) LU83820A1 (fr)
MX (1) MX7096E (fr)
NL (1) NL8105468A (fr)
NO (1) NO160297C (fr)
NZ (1) NZ199168A (fr)
PT (1) PT74087B (fr)
SE (1) SE8107273L (fr)
SU (2) SU1662348A3 (fr)
WO (1) WO1982002042A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU557649B2 (en) * 1981-03-30 1987-01-08 E.R. Squibb & Sons, Inc. 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts
US4734496A (en) * 1981-05-29 1988-03-29 E. R. Squibb & Sons, Inc. 4-amino derivatives of 2-oxo-1-azetidinesulfonic acid salts
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類
IT1157292B (it) * 1981-07-16 1987-02-11 Squibb & Sons Inc Derivati 4-sostituiti dei sali dell'acido 2-osso-1-azetidinsolfonico e procedimento per la loro preparazione
DE3274981D1 (en) * 1981-10-05 1987-02-12 Squibb & Sons Inc 4-ether derivatives of 2-azetidinone-1-sulfonic acids
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 2−オキソアゼチジン誘導体、その製造法および用途
JPS5916888A (ja) * 1982-07-20 1984-01-28 Takeda Chem Ind Ltd 1−スルホ−2−アゼチジノン誘導体およびその製造法
US4681937A (en) * 1982-09-27 1987-07-21 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters
JPS59101485A (ja) * 1982-11-29 1984-06-12 Otsuka Chem Co Ltd アセチジノン誘導体
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
WO1988006587A1 (fr) * 1987-02-27 1988-09-07 The Upjohn Company beta LACTAMES ANTIBIOTIQUES CONTENANT UN ACIDE PYRIDONE CARBOXYLIQUE OU UN ACIDE DERIVE
CA1317298C (fr) * 1987-03-03 1993-05-04 Upjohn Company (The) .beta.-lactames antibiotiques activees par des groupes sulfonylaminocar bonyles
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
DE69711926D1 (de) * 1996-09-23 2002-05-16 Naeja Pharmaceutical Inc 3,4-disubstituierte azetidin-2-on-derivate die als cystein-proteinase regulatoren nuetzlich sind

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6046955B2 (ja) * 1977-12-30 1985-10-18 武田薬品工業株式会社 抗生物質g−6302
JPS5549394A (en) * 1978-10-03 1980-04-09 Takeda Chem Ind Ltd Antibiotic substance sb-72310
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
CA1242188A (fr) * 1979-06-08 1988-09-20 Takeda Pharmaceutical Company Limited Derives de 3-methoxy-2-oxoazetidine et leur preparation
DE3069587D1 (en) * 1979-06-08 1984-12-13 Takeda Chemical Industries Ltd 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
NZ196202A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)
AU557649B2 (en) * 1981-03-30 1987-01-08 E.R. Squibb & Sons, Inc. 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類
IT1157292B (it) * 1981-07-16 1987-02-11 Squibb & Sons Inc Derivati 4-sostituiti dei sali dell'acido 2-osso-1-azetidinsolfonico e procedimento per la loro preparazione
FR2515182B1 (fr) * 1981-10-23 1986-05-09 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Also Published As

Publication number Publication date
FI79528B (fi) 1989-09-29
ES8305325A1 (es) 1983-04-01
DE3148020A1 (de) 1982-10-21
IT1146726B (it) 1986-11-19
KR830007549A (ko) 1983-10-21
ES513420A0 (es) 1983-04-01
GB2091723A (en) 1982-08-04
WO1982002042A1 (fr) 1982-06-24
FI79528C (fi) 1990-01-10
EP0053815A1 (fr) 1982-06-16
NO160297C (no) 1989-04-05
DE3170437D1 (en) 1985-06-13
ES8301915A1 (es) 1982-12-16
FR2495612A1 (fr) 1982-06-11
MX7096E (es) 1987-06-19
SU1531852A3 (ru) 1989-12-23
IE53451B1 (en) 1988-11-23
AT380471B (de) 1986-05-26
SE8107273L (sv) 1982-06-06
AT379800B (de) 1986-02-25
FR2495612B1 (fr) 1984-06-01
PT74087B (en) 1983-05-23
NZ199168A (en) 1985-08-30
LU83820A1 (fr) 1982-05-07
US4822790A (en) 1989-04-18
ATA520781A (de) 1985-07-15
IL64314A0 (en) 1982-02-28
SU1662348A3 (ru) 1991-07-07
CH656122A5 (de) 1986-06-13
PT74087A (en) 1982-01-01
AU551463B2 (en) 1986-05-01
IE812859L (en) 1982-06-05
NO160297B (no) 1988-12-27
IT8168585A0 (it) 1981-12-04
AU7831381A (en) 1982-06-10
JPS57131759A (en) 1982-08-14
KR880001564B1 (ko) 1988-08-22
GB2091723B (en) 1985-06-12
NO814113L (no) 1982-06-07
FI813851L (fi) 1982-06-06
DK534381A (da) 1982-06-06
ES507716A0 (es) 1982-12-16
HU189545B (en) 1986-07-28
EP0053815B1 (fr) 1985-05-08
ATE13178T1 (de) 1985-05-15
ATA170384A (de) 1985-10-15
NL8105468A (nl) 1982-07-01

Similar Documents

Publication Publication Date Title
IL64314A (en) 2-oxoazetidine derivatives,their production and antimicrobial and beta-lactamase inhibitory compositions containing them
HUT59676A (en) Process for producing piperazinyl-alkyl-carbonyl derivatives of condensed heterocyclic compounds and pharmaceutical compositions containing them
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
ATE146476T1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
FI895139A0 (fi) Pyrrolidinderivat.
ES8303327A1 (es) Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina .